Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.93
-0.26 (-2.32%)
May 26, 2026, 2:36 PM EDT - Market open
Keros Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +46.39% | May 19, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 | Buy | Maintains | $20 | +82.98% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +82.98% | May 15, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 14, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $30 | Buy | Reiterates | $30 | +174.47% | Mar 6, 2026 |
| Raymond James | Raymond James | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | +82.98% | Mar 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.